Life Sciences & Medicine Active Updated Nov 20, 2026

A gene dimmer switch for drug-resistant epilepsy

Where it stands as of Nov 20, 2026

Three men who had lived with epilepsy for at least a decade saw monthly seizures drop by more than 90 percent in a pilot chemogenetic gene therapy trial, and one stayed seizure-free for a year. The evidence is three patients in an early trial. Whether the effect holds in larger groups and over longer follow-up is not known.

The story so far

  1. Nov 20, 2026 Latest

    SingularityHub reported that three men with epilepsy for at least a decade saw monthly seizures fall by more than 90 percent in a pilot trial, and one stayed seizure-free for a year. The team delivered a gene into the hippocampal patch where seizures began, and the protein it makes turns that region's activity down when an FDA-approved drug activates it. Dimitri Kullmann of University College London, who was not involved, said it has caused a lot of excitement in the field.

    Today Got Better

This story moves with the morning letter.

When this question gets a new answer, the page above changes the same morning. Each morning's letter brings the day's progress in science, medicine and beyond. Free, every day.